Preetham Ravi

Preetham Ravi

Auto-generated profile, based on publicly available information

Preetham Ravi

Mayo Clinic

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
PRPreetham Ravi
Preetham Ravi
SGShrinwanti Ghosh
Shrinwanti Ghosh
PPPooyan Vahidi Pashaki
Pooyan Vahidi Pashaki
Kalidas ShettyKalidas Shetty
Kalidas Shetty
JKJiha Kim
Jiha Kim
KKKalpana S Katti
Kalpana S Katti

8 February 2026 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PPPooyan Vahidi Pashaki
Pooyan Vahidi Pashaki
PRPreetham Ravi
Preetham Ravi
SJSharad V. Jaswandkar
Sharad V. Jaswandkar
BNBenjamin Noonan
Benjamin Noonan
KKKalpana S Katti
Kalpana S Katti
DKDinesh Ramanath Katti
Dinesh Ramanath Katti

Verified
Journal Article
Open access
PDF file
PRPreetham Ravi
Preetham Ravi
HJHaneesh Jasuja
Haneesh Jasuja
DSDipayan Sarkar
Dipayan Sarkar
DKDinesh Ramanath Katti
Dinesh Ramanath Katti
Kalidas ShettyKalidas Shetty
Kalidas Shetty
KKKalpana S Katti
Kalpana S Katti
Bone metastasis remains a fatal and incurable condition for patients with breast cancer, leading to skeletal deterioration. The bone microenvironment enhances tumor proliferation and chemoresistance, necessitating novel therapeutic strategies. To investigate the cytotoxicity of two phytochemically-enriched plant extracts: Origanum vulgare (O.V.) and Vaccinium macrocarpon (V.M.) against breast cancer cells in a bone-metastatic condition. MCF-7 and MDA-MB-231 cell lines were treated with O.V. and V.M. for 24 h, in both 2D and 3D bone metastatic conditions. Live cell imaging, Alamar blue viability assay, RT-PCR, and flow cytometry analysis were used to assess cytotoxicity, apoptosis activation, and changes in oxidative stress/mitochondrial activity. Both extracts significantly inhibited cancer cell growth in a dose-dependent manner, with differential sensitivity observed between cell lines. Based on IC50 analysis, O.V. demonstrated greater efficacy against the bone metastatic MCF-7 cell line, while V.M. was more effective against the bone metastatic MDA-MB-231. Apoptosis activation was confirmed via upregulation of pro-apoptotic proteins p53 and caspase-9. Importantly, we observed that normal bone cells were unaffected by the treatments. These findings elucidate the promising yet untapped potential of O.V. and V.M. extracts as robust therapies for bone metastasis.

8 April 2026 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
PRPreetham Ravi
Preetham Ravi
SGShrinwanti Ghosh
Shrinwanti Ghosh
SJSharad V. Jaswandkar
Sharad V. Jaswandkar
PPPooyan Vahidi Pashaki
Pooyan Vahidi Pashaki
DHDavid Ha
David Ha
KKKalpana S Katti
Kalpana S Katti

29 July 2026 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Open access
MNMaunick Lefin Koloko Ngassie
Maunick Lefin Koloko Ngassie
YOYamillie Ortiz
Yamillie Ortiz
PRPreetham Ravi
Preetham Ravi
DPDaniel A. Pfeffer-Kleemann
Daniel A. Pfeffer-Kleemann
SHSamantha K. Hamrick
Samantha K. Hamrick
YPY. S. Prakash
Y. S. Prakash
Iron is essential for cellular function, and lung cells are no exception. Previous studies have demonstrated an association between increased level of iron in the lung and aging and age-related lung diseases including pulmonary fibrosis and asthma in the elderly (AIE). However, the mechanisms underlying the accumulation of iron with aging or AIE, or the cell types involved, remain understudied. In the context of asthma, airway smooth muscle is a key cell type contributing to contractility as well as airway remodeling (proliferation, fibrosis). In this study we characterized iron level and regulation in human (hASM) from young (<45 yr), old (≥65 yr) and AIE (≥65 yr) male/female patients, and investigated the contribution of iron overload in hASM to airway remodeling. Cells were treated with ferric ammonium citrate (FAC) (100 μM; 72h) or iron chelator deferoxamine (DFO) (100 µM; 72h). Basal levels of intracellular ferrous iron (Fe 2+ ) were determined using the fluorescent dye FerroOrange. Cell lysates were analyzed for iron accumulation, antioxidant, lipid peroxidation, and extracellular matrix (ECM) markers, and cell proliferation was assessed. We found that iron accumulates with aging, but surprisingly decreases with AIE. hASM from AIE patients showed activated antioxidant pathways and lipid peroxidation, while FAC-exposure impaired iron metabolism and enhanced ECM deposition. Iron depletion mitigated the antioxidant response, lipid peroxidation, cell proliferation, ECM production. These findings suggest that iron metabolism in hASM contributes to cell hyperplasia and ECM, while in aging and particularly AIE, counter-regulatory changes in iron metabolism and antioxidant pathways occur, overall promoting airway remodeling.

1 September 2026 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
MTMichael A. Thompson
Michael A. Thompson
SHSamantha K. Hamrick
Samantha K. Hamrick
NBNiyati A. Borkar
Niyati A. Borkar
PRPreetham Ravi
Preetham Ravi
YCYagiz anil Cicek
Yagiz anil Cicek
YPY. S. Prakash
Y. S. Prakash
SiRNA delivery to target cellular processes is an appealing area in lung diseases such as asthma. To realize this potential requires efficient, targeted cytosolic delivery without cellular toxicity or siRNA degradation. We demonstrate the efficacy of PONI-Guan nanoparticles in accessing airway epithelial and smooth muscle cells with specific siRNA targeting of mRNAs of interest while maintaining barrier integrity and avoiding cellular toxicity.